124 related articles for article (PubMed ID: 3390345)
1. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx.
Overgaard J; Hjelm-Hansen M; Johansen LV; Andersen AP
Acta Oncol; 1988; 27(2):147-52. PubMed ID: 3390345
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell repopulation in the rest interval of split-course radiation treatment.
Budihna M; Skrk J; Smid L; Furlan L
Strahlentherapie; 1980 Jun; 156(6):402-8. PubMed ID: 7423563
[TBL] [Abstract][Full Text] [Related]
3. Dose, time, and fraction size issues for late effects in head and neck cancers.
Taylor JM; Mendenhall WM; Lavey RS
Int J Radiat Oncol Biol Phys; 1992; 22(1):3-11. PubMed ID: 1727126
[TBL] [Abstract][Full Text] [Related]
4. Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx.
Maciejewski B; Taylor JM; Withers HR
Radiother Oncol; 1986 Dec; 7(4):323-6. PubMed ID: 3809591
[TBL] [Abstract][Full Text] [Related]
5. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
Garden AS; Morrison WH; Ang KK; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma.
Keane TJ; Cummings BJ; O'Sullivan B; Payne D; Rawlinson E; MacKenzie R; Danjoux C; Hodson I
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):613-8. PubMed ID: 8454478
[TBL] [Abstract][Full Text] [Related]
7. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
Eriksen JG; Steiniche T; Overgaard J;
Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
[TBL] [Abstract][Full Text] [Related]
8. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
[TBL] [Abstract][Full Text] [Related]
9. Hyperfractionation as an altered fractionation regimen in primary radiotherapy for squamous cell carcinoma of the larynx.
Krstevska V; Smichkoska S
Prilozi; 2006 Dec; 27(2):175-87. PubMed ID: 17211301
[TBL] [Abstract][Full Text] [Related]
10. Early results of radiotherapy for advanced laryngeal cancer using three small fractions per day.
Morgan DA; Bradley PJ; MacLennan KA
Acta Oncol; 1987; 26(6):437-40. PubMed ID: 3446242
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy of advanced laryngeal cancer using three small fractions daily.
Bradley PJ; Morgan DA
Otolaryngol Head Neck Surg; 1991 Jun; 104(6):838-41. PubMed ID: 1908977
[TBL] [Abstract][Full Text] [Related]
12. Results of radiotherapy of carcinoma laryngis in relation to the mode of dose fractionation.
Durkovský J; Sevcíková L; Miklánková M
Neoplasma; 1981; 28(5):599-609. PubMed ID: 7312078
[TBL] [Abstract][Full Text] [Related]
13. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
Krstevska V; Crvenkova S
Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
[TBL] [Abstract][Full Text] [Related]
14. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.
Poulsen MG; Denham JW; Peters LJ; Lamb DS; Spry NA; Hindley A; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q
Radiother Oncol; 2001 Aug; 60(2):113-22. PubMed ID: 11439206
[TBL] [Abstract][Full Text] [Related]
15. Laryngeal carcinoma. IV. Analysis of treatment results using the Cohen model.
Hjelm-Hansen M
Acta Radiol Oncol; 1980; 19(1):3-12. PubMed ID: 6246727
[TBL] [Abstract][Full Text] [Related]
16. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
[TBL] [Abstract][Full Text] [Related]
17. Importance of dose per fraction and estimation of an alpha/beta value for the late complications of the vocal cord.
Deore SM; Supe SJ; Sharma V; Dinshaw KA
Strahlenther Onkol; 1991 Oct; 167(10):608-11. PubMed ID: 1948646
[TBL] [Abstract][Full Text] [Related]
18. Pharyngo-cutaneous fistulae after laryngectomy. Influence of previous radiotherapy and prophylactic metronidazole.
Johansen LV; Overgaard J; Elbrønd O
Cancer; 1988 Feb; 61(4):673-8. PubMed ID: 3338032
[TBL] [Abstract][Full Text] [Related]
19. Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity.
Kaanders JH; van Daal WA; Hoogenraad WJ; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 1992; 24(3):497-503. PubMed ID: 1399736
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy.
Rezvani M; Fowler JF; Hopewell JW; Alcock CJ
Br J Radiol; 1993 Mar; 66(783):245-55. PubMed ID: 8472118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
